Early prenatal exposure to immunosuppressive drugs not linked to harm

11/3/2013 | MedPage Today (free registration)

Taking immunosuppressive drugs to treat autoimmune diseases during the first trimester of pregnancy was not associated with significantly higher rates of adverse fetal events such as congenital malformations and fetal death, according to a U.S. study published in the journal Arthritis & Rheumatism.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX